We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.07T
$105M 0.46%
383,608
+33,849
+10% +$9.51M
NFLX icon
27
Netflix
NFLX
$292B
$103M 0.45%
1,689,520
+89,460
+6% +$4.92M
NEE.PRO
28
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
$98.2M 0.43%
1,675,542
-20,787
-1% -$1.25M
TSLA icon
29
Tesla
TSLA
$1.24T
$97.8M 0.43%
378,489
+41,070
+12% +$9.67M
LIN icon
30
Linde
LIN
$237B
$90.2M 0.39%
307,419
+13,518
+5% +$4.11M
NKE icon
31
Nike
NKE
$61.9B
$89.5M 0.39%
616,186
+22,191
+4% +$3.62M
HON icon
32
Honeywell
HON
$77.1B
$89.2M 0.39%
445,961
-6,118
-1% -$1.3M
PG icon
33
Procter & Gamble
PG
$343B
$89.2M 0.39%
637,829
+38,237
+6% +$5.42M
MS icon
34
Morgan Stanley
MS
$337B
$88.1M 0.38%
905,633
+35,078
+4% +$3.48M
UNP icon
35
Union Pacific
UNP
$183B
$87.4M 0.38%
445,798
+16,192
+4% +$3.5M
KO icon
36
Coca-Cola
KO
$354B
$86.4M 0.38%
1,647,045
+78,042
+5% +$4.35M
RTX icon
37
RTX Corp
RTX
$287B
$84.7M 0.37%
985,524
+5,835
+0.6% +$499K
CVX icon
38
Chevron
CVX
$388B
$84.4M 0.37%
832,055
+30,527
+4% +$3.04M
WMT icon
39
Walmart Inc
WMT
$871B
$83.9M 0.37%
1,805,910
+24,615
+1% +$1.19M
WFC icon
40
Wells Fargo
WFC
$261B
$81.4M 0.36%
1,754,147
+33,305
+2% +$1.54M
CSX icon
41
CSX Corp
CSX
$98.6B
$81.3M 0.36%
2,734,634
+133,286
+5% +$4.27M
CMCSA icon
42
Comcast
CMCSA
$79.1B
$79.6M 0.35%
1,423,124
+89,151
+7% +$5.2M
ACN icon
43
Accenture
ACN
$89.9B
$78.6M 0.34%
245,703
+12,389
+5% +$4.03M
GS icon
44
Goldman Sachs
GS
$313B
$76.7M 0.34%
202,914
+745
+0.4% +$291K
CSCO icon
45
Cisco
CSCO
$450B
$76.4M 0.33%
1,403,738
+103,729
+8% +$5.82M
TMO icon
46
Thermo Fisher Scientific
TMO
$211B
$75.5M 0.33%
132,153
+35,890
+37% +$19.7M
SWT
47
DELISTED
Stanley Black & Decker, Inc.
SWT
$72.8M 0.32%
691,428
-33,519
-5% -$3.88M
PFE icon
48
Pfizer
PFE
$140B
$67.4M 0.29%
1,567,190
+177,387
+13% +$7.86M
IWM icon
49
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$66.5M 0.29%
+304,000
New +$67.4M
COST icon
50
Costco
COST
$415B
$65.4M 0.29%
145,590
+23,031
+19% +$10.1M

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.